Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
502.6 INR | -3.69% | -6.33% | +52.15% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 137M | Sales 2023 | 10.52B 126M | Capitalization | 19.91B 239M |
---|---|---|---|---|---|
Net income 2022 | 607M 7.27M | Net income 2023 | -325M -3.89M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.84M | Net Debt 2023 | 7.79B 93.36M | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | 1,179 |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Limited
1 day | -3.69% | ||
1 week | -6.33% | ||
Current month | -8.69% | ||
1 month | +1.34% | ||
3 months | +39.02% | ||
6 months | +40.89% | ||
Current year | +52.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 21-05-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Director/Board Member | 58 | 21-09-01 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 21-09-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 502.6 | -3.69% | 331 206 |
24-05-06 | 521.8 | -2.84% | 219,993 |
24-05-03 | 537 | -3.12% | 405,041 |
24-05-02 | 554.4 | +0.73% | 283,816 |
24-04-30 | 550.4 | +2.58% | 596,856 |
Delayed Quote NSE India S.E., May 07, 2024 at 07:43 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.36% | 690B | |
+26.43% | 546B | |
-5.16% | 358B | |
+19.36% | 323B | |
+4.88% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.14% | 161B |
- Stock Market
- Equities
- SHILPAMED Stock
- SHILPAMED Stock